WC
Insider
William J Chase
DirectorWilliam J Chase (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Intellia Therapeutics, Inc. (NTLA). Across 1 priced purchase filing, the average 21-session return was +57.5% from execution and +68.7% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of NTLA (100,000 sh × $10.03, as filed), executed Aug 20 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+57.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+68.7%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.0M
shares × price, as filed
Last traded
Aug 20 2025
Filed Aug 22 2025
Median ADV $62.4M across their filed names
Open performance→Volume by month
Buys $1.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
NTLARecent filings
NTLAPURCHASE
Intellia Therapeutics, Inc.
View filing →
$1.0M100,000 sh × $10.03
Exec Aug 20 2025
Filed Aug 22 2025 · 4:30 PM ET